耐火性血管缩性心血管炎由支气管喘复杂化,带有异性爱素
Naomi Nakazawa1, Toshiomi Katsuki1, Taishi Fujisawa1
1Department of Cardiology, Saitama Municipal Hospital, Japan.
Internal medicine (Tokyo, Japan)
|October 14, 2024
概括
梅波利祖马布有效地治疗了患有喘和eosinophilia的患者的耐火性冠状动脉血管. 这表明mepolizumab可能是类似复杂的心血管和呼吸系统疾病的新疗法选择.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 一名患有支气管喘和过敏性鼻炎病史的患者因心室动而心脏骤停.
- 冠状动脉扫描确定冠状动脉作为原因,这是耐标准抗剂的耐火性.
研究的目的:
- 调查耐火性冠状动脉血管的替代干预措施.
- 评估以乙氨基酸为向治疗在治疗与喘和乙氨基酸相关的耐火性冠状动脉血管的潜在作用.
主要方法:
- 这名患者接受了美波利祖马布 (mepolizumab) 治疗,该药物用于治疗酸性喘.
- 监测了乙氨基细胞数量,并评估了冠状动脉血管的临床结果.
主要成果:
- 梅波利祖马布的使用使患者的高氨基酸细胞数量正常化.
- 患者在梅波利祖马布治疗后仍然没有复发的冠状动脉.
结论:
- 梅波利祖马布在该患者的耐火性冠状动脉血管的解决方面表现出有效性.
- 这一案例表明,美波利祖马布可能是与支气管喘和eosinophilia相关的耐火性冠状动脉心痛的潜在治疗方法.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
363
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
241
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
241


